Here is the trustworthy respond to: VIP just isn't a standard-reason anti-inflammatory peptide you could substitute into any protocol expecting broad immune suppression. Its effects are receptor-distinct, tissue-dependent, and timing-delicate in ways that make protocol design and style noticeably ex